P-Glycoprotein (Abcb1) is involved in absorptive drug transport in skin

被引:32
作者
Ito, Katsuaki [1 ]
Nguyen, Hai Thien [1 ]
Kato, Yukio [1 ]
Wakayama, Tomohiko [2 ]
Kubo, Yoshiyuki [1 ]
Iseki, Shoichi [2 ]
Tsuji, Akira [1 ]
机构
[1] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa 9208641, Japan
关键词
Skin; Transporter; P-glycoprotein; ABCB1; Transdermal permeation;
D O I
10.1016/j.jconrel.2008.08.004
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The purpose of the present study was to investigate the role of P-glycoprotein (P-gp) in drug disposition in skin. The distribution of P-gp substrates (rhodamine 123 and itraconazole) to the skin after administration from the epidermal side was lower in P-gp gene knockout (mdr1a/1b(-/-)) mice than that in wild-type mice. Coadministration of propranolol, a P-gp inhibitor, decreased the distribution of itraconazole to the skin in wild-type mice, but not in mdr1a/1b(-/-) mice. These results suggest that P-gp contributes to the influx (from the epidermal side) of its substrates into skin, although P-gp is generally involved in efflux of drugs from various tissues. This finding was supported by the lower vectorial transport of rhodamine 123 from the epidermal to the hypodermal side in mdr1a/1b(-/-) mice in Ussing-type chamber experiments and by the immunohistochemical localization of P-gp throughout the dermal layer. Distribution of itraconazole after intravenous administration, on the other hand, was higher in mdr1a/1b(-/-) mice than that in wild-type mice, suggesting that P-gp transports this drug from the skin to the circulation. The present findings are the first to demonstrate involvement of P-gp in dermal drug disposition. (c) 2008 Published by Elsevier B.V.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 40 条
[1]   Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats [J].
Ando, H ;
Nishio, Y ;
Ito, K ;
Nakao, A ;
Wang, L ;
Zhao, YL ;
Kitaichi, K ;
Takagi, K ;
Hasegawa, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3462-3467
[2]   Characterization of β-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein [J].
Bachmakov, I ;
Werner, U ;
Endress, B ;
Auge, D ;
Fromm, MF .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2006, 20 (03) :273-282
[3]   Does inhibition of P-glycoprotein lead to drug-drug interactions? [J].
Balayssac, D ;
Authier, N ;
Cayre, A ;
Coudore, F .
TOXICOLOGY LETTERS, 2005, 156 (03) :319-329
[4]   Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes [J].
Baron, JM ;
Höller, D ;
Schiffer, R ;
Frankenberg, S ;
Neis, M ;
Merk, HF ;
Jugert, FK .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (04) :541-548
[5]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[6]   Unmasking the dynamic interplay between efflux transporters and metabolic enzymes [J].
Benet, LZ ;
Cummins, CL ;
Wu, CY .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 277 (1-2) :3-9
[7]  
BITTL A, 1995, ANTICANCER RES, V15, P1007
[8]   Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592
[9]  
Gupta AK, 1998, CLIN EXP DERMATOL, V23, P103, DOI 10.1046/j.1365-2230.1998.00319.x
[10]   Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations [J].
Gutierrez, G. E. ;
Lalka, D. ;
Garrett, I. R. ;
Rossini, G. ;
Mundy, G. R. .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (07) :1033-1042